Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Mallinson, S. Rajabiun, S. Coleman (2007)
The provider role in client engagement in HIV care.AIDS patient care and STDs, 21 Suppl 1
R. Royce, A. Seña, W. Cates, W. Cates, M. Cohen (1997)
Sexual transmission of HIV.The New England journal of medicine, 336 15
Kathleen Falster, L. Gelgor, Ansari Shaik, I. Zablotska, G. Prestage, J. Grierson, R. Thorpe, M. Pitts, Jonathan Anderson, J. Chuah, B. Mulhall, K. Petoumenos, A. Kelleher, M. Law (2008)
Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment.Sexual health, 5 2
M. Hull, Zunyou Wu, J. Montaner (2012)
Optimizing the engagement of care cascade: a critical step to maximize the impact of HIV treatment as preventionCurrent Opinion in HIV and AIDS, 7
R. Gold, Damien Ridge (2001)
"I will start treatment when I think the time is right": HIV-positive gay men talk about their decision not to access antiretroviral therapyAIDS Care, 13
P. Sax, L. Baden (2009)
When to start antiretroviral therapy--ready when you are?The New England journal of medicine, 360 18
Persson A
Facing HIV: body shape change and
A. Strauss (1987)
Qualitative Analysis For Social Scientists
J. Murray, G. Prestage, J. Grierson, Melanie Middleton, A. McDonald (2011)
Increasing HIV diagnoses in Australia among men who have sex with men correlated with the growing number not taking antiretroviral therapy.Sexual health, 8 3
R. Granich, C. Gilks, C. Dye, K. Cock, B. Williams (2009)
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical modelThe Lancet, 373
V. Jain, S. Deeks (2010)
When to Start Antiretroviral TherapyCurrent HIV/AIDS Reports, 7
Smith K Powers KA Kashuba AD Cohen MS
HIV-1 treatment as prevention: the good, the bad, and the challenges. Curr Opin HIV AIDS .
Christy Newman, Asha Persson, Jeanne Ellard (2006)
‘We just don’t know’: ambivalence about treatment strategies in the Australian community-based HIV mediaHealth, 10
M. Kitahata, S. Gange, A. Abraham, Barry Merriman, M. Saag, A. Justice, R. Hogg, S. Deeks, J. Eron, J. Brooks, S. Rourke, M. Gill, R. Bosch, Jeffrey Martin, M. Klein, L. Jacobson, B. Rodriguez, T. Sterling, G. Kirk, S. Napravnik, A. Rachlis, L. Calzavara, M. Horberg, M. Silverberg, K. Gebo, J. Goedert, C. Benson, A. Collier, S. Rompaey, H. Crane, R. Mckaig, B. Lau, Aimee Freeman, Richard Moore (2009)
The new england journal of medicine Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
Myron Cohen, Ying Chen, M. McCauley, T. Gamble, Mina Hosseinipour, N. Kumarasamy, James Hakim, J. Kumwenda, Beatriz Grinsztejn, J. Pilotto, S. Godbole, Sanjay Mehendale, S. Chariyalertsak, B. Santos, Kenneth Mayer, I. Hoffman, S. Eshleman, E. Piwowar-Manning, Lei Wang, J. Makhema, Lisa Mills, Guy Bruyn, Ian Sanne, Joseph Eron, J. Gallant, D. Havlir, S. Swindells, Heather Ribaudo, V. Elharrar, David Burns, T. Taha, Karin Nielsen-Saines, D. Celentano, Max Essex, Thomas Fleming (2011)
Prevention of HIV-1 infection with early antiretroviral therapy.The New England journal of medicine, 365 6
R. Gregory, E. Peters, P. Slovic (2011)
Making decisions about prescription drugs: A study of doctor–patient communicationHealth, Risk & Society, 13
K. Race (2001)
The Undetectable Crisis: Changing Technologies of RiskSexualities, 4
M. Law, G. Prestage, A. Grulich, P. Ven, S. Kippax (2001)
Modelling the effect of combination antiretroviral treatments on HIV incidenceAIDS, 15
Alethea McCormick, R. Walensky, M. Lipsitch, E. Losina, E. Losina, H. Hsu, M. Weinstein, A. Paltiel, K. Freedberg, G. Seage (2007)
The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 44 8
Kitahata MM Gange SJ Abraham AG Merriman B Saag MS Justice AC et al
Effect of early versus deferred antiretroviral therapy for HIV on survival.
G. Gellaitry, V. Cooper, C. Davis, Mark Fisher, H. Date, R. Horne (2005)
Patients’ perception of information about HAART: impact on treatment decisionsAIDS Care, 17
D. Wilson, A. Hoare, D. Regan, M. Law (2009)
Importance of promoting HIV testing for preventing secondary transmissions: modelling the Australian HIV epidemic among men who have sex with men.Sexual health, 6 1
J. Currier, L. Baden (2006)
Getting smarter--the toxicity of undertreated HIV infection.The New England journal of medicine, 355 22
Asha Persson (2005)
Facing HIV: Body Shape Change and the (in)Visibility of IllnessMedical Anthropology, 24
Kumi Smith, K. Powers, A. Kashuba, M. Cohen (2011)
HIV-1 treatment as prevention: the good, the bad, and the challengesCurrent Opinion in HIV and AIDS, 6
B. Nosyk, Bertrand Audoin, C. Beyrer, P. Cahn, R. Granich, D. Havlir, E. Katabira, J. Lange, V. Lima, T. Patterson, S. Strathdee, B. Williams, J. Montaner (2013)
Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteriaAIDS, 27
Z. Jia, Y. Mao, Fujie Zhang, Y. Ruan, Ye Ma, Jian Li, W. Guo, E. Liu, Z. Dou, Yan Zhao, Lu Wang, Qianqian Li, P. Xie, Hou-lin Tang, Jing-xiu Han, Xia Jin, Juan Xu, R. Xiong, De-cai Zhao, Ping Li, Xia Wang, Li-yan Wang, Qianqian Qing, Zhengwei Ding, Ray Chen, Zhong-fu Liu, Y. Shao (2013)
Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003–11): a national observational cohort studyThe Lancet, 382
H. Kremer, G. Ironson, N. Schneiderman, M. Hautzinger (2006)
To take or not to take: decision-making about antiretroviral treatment in people living with HIV/AIDS.AIDS patient care and STDs, 20 5
D. Wilson, M. Law, A. Grulich, D. Cooper, J. Kaldor (2008)
Relation between HIV viral load and infectiousness: a model-based analysisThe Lancet, 372
R. Horne, V. Cooper, G. Gellaitry, H. Date, M. Fisher (2007)
Patients' Perceptions of Highly Active Antiretroviral Therapy in Relation to Treatment Uptake and Adherence: The Utility of the Necessity-Concerns FrameworkJAIDS Journal of Acquired Immune Deficiency Syndromes, 45
M. Rosengarten, J. Imrie, P. Flowers, M. Davis, G. Hart (2004)
After the euphoria: HIV medical technologies from the perspective of their prescribers.Sociology of health & illness, 26 5
Jonathan Sterne, Margaret May, D. Costagliola, F. Wolf, A. Phillips, Ross Harris, Michele Funk, Ronald Geskus, John Gill, F. Dabis, J. Miró, Amy Justice, B. Ledergerber, G. Fätkenheuer, Robert Hogg, A. Monforte, M. Saag, Colette Smith, Schlomo Staszewski, M. Egger, Stephen Cole (2009)
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studiesLancet, 373
K. Mayer, K. Venkatesh (2010)
Antiretroviral therapy as HIV prevention: status and prospects.American journal of public health, 100 10
V. Cooper, D. Buick, R. Horne, N. Lambert, G. Gellaitry, H. Leake, M. Fisher (2002)
Perceptions of HAART among gay men who declined a treatment offer: Preliminary results from an interview-based studyAIDS Care, 14
E. Gardner, Margaret Mclees, J. Steiner, C. Rio, W. Burman (2011)
The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 52 6
M. Smith, K. Powers, Kathryn Muessig, William Miller, Myron Cohen (2012)
HIV Treatment as Prevention: The Utility and Limitations of Ecological ObservationPLoS Medicine, 9
A. Fauci, J. Bartlett, E. Goosby, M. Smith, H. Kaiser, S. Chang, Jean Anderson, R. Armstead, A. Baker, David Barr, S. Bozzette, S. Cox, M. Delaney, F. Gordin, W. Greaves, M. Harrington, J. Henning, M. Hirsch, J. Jacobs, R. Marlink, C. Maxwell, J. Mellors, D. Nash, S. Perryman, R. Schooley, R. Sherer, S. Spector, G. Torres, P. Volberding, B. Brady, E. Daniels, D. Feigal, M. Feinberg, H. Gayle, T. Graydon, J. Kaplan, A. Macher, R. Martin, H. Masur, L. Mofenson, J. Murray, J. O'Neill, L. Pérez, R. Riseberg, S. Shekar, S. Stanley, J. Whitescarver (1998)
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000HIV Clinical Trials, 1
M. Beach, Patrick Duggan, Richard Moore (2007)
Is Patients’ Preferred Involvement in Health Decisions Related to Outcomes for Patients with HIV?Journal of General Internal Medicine, 22
Asha Persson, Christy Newman (2006)
Potency and vulnerability: troubled 'selves' in the context of antiretroviral therapy.Social science & medicine, 63 6
J. Montaner, R. Hogg, E. Wood, T. Kerr, M. Tyndall, Adrian Levy, P. Harrigan (2006)
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemicThe Lancet, 368
BackgroundIn recent years, there has been increasing evidence that early initiation of antiretroviral therapy (ART) may provide health benefits for those infected with HIV. There has also been significant discussion about the role of HIV treatment in preventing onward transmission of the virus. Early provision and uptake of ART to people recently diagnosed with HIV could achieve both individual and public health outcomes. The success of such an initiative relies, in part, on the preparedness of those recently diagnosed with HIV to engage with the therapy. Methods: The HIV Seroconversion Study collects both quantitative and qualitative data from people in Australia who have recently been diagnosed with HIV. During 20112012, 53 gay or bisexual men recruited across Australia took part in semistructured interviews as part of the study. The men were asked about their knowledge and experience of, and their decisions about whether or not to commence, HIV treatment. Results: The interviews identified differing levels of knowledge about HIV treatments and divergent views about the health and prevention benefits of ART. For some, treatments provided a sense of control over the virus others were apprehensive and distrustful, and preferred to resist commencing treatments for as long as possible. Conclusions: If early initiation of treatment is to be encouraged, appropriate measures must be in place to ensure recently diagnosed individuals have access to the appropriate information and the support they need to enable them to make informed choices and, if necessary, to address their fears.
Sexual Health – CSIRO Publishing
Published: Jul 10, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.